Home > Financial Ratios > GLAND PHARMA

GLAND PHARMA
EBIT Growth

    Back to All Ratios
GLAND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Last 5 Year EBIT Growth History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   EBIT Growth(%) 35.59-4.679.11-34.6021.34

What is the latest EBIT Growth ratio of GLAND PHARMA ?

The latest EBIT Growth ratio of GLAND PHARMA is 35.59 based on Mar2026 Consolidated results.
Year EBIT Growth
Mar202635.59
Mar2025-4.67
Mar20249.11
Mar2023-34.60
Mar202221.34

How is EBIT Growth of GLAND PHARMA Trending?

Years EBIT Growth % Change
Mar2026 35.59
Positive
Mar2025 -4.67
Negative
Mar2024 9.11
Positive
Mar2023 -34.6
Negative
Mar2022 21.34 -

Other Financial Ratios of GLAND PHARMA


Compare EBIT Growth ratio of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹42,525.5 Cr 3.2% 2.4% 24.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹467,870.0 Cr 0.8% 6.3% 18.2% Stock Analytics
DIVIS LABORATORIES ₹220,946.0 Cr 8.6% 20.7% 18.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹190,907.0 Cr 1.7% 9.4% 38.5% Stock Analytics
CIPLA ₹118,674.0 Cr 4.5% 1.2% -1.4% Stock Analytics
DR REDDYS LABORATORIES ₹97,648.7 Cr -0.3% -14.8% -9.5% Stock Analytics


GLAND PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

3.2%

2.4%

24.7%

SENSEX

2.4%

1.5%

-4.3%


You may also like the below Video Courses